AIF1 and neoplasm: Compared with naive tumor, neoadjuvant ddACT chemotherapy treatment expanded the tumor-infiltrating Iba1+pStat1+ cells (white arrows) from a mean of 13% (Vehicle treated) to 25% (chemo-treated) of all the Iba1+ cells (Supplementary Fig. 3i, j and Supplementary Data 6).